151 related articles for article (PubMed ID: 26542197)
1. Effect of socioeconomic deprivation on uptake of measles, mumps and rubella vaccination in Liverpool, UK over 16 years: a longitudinal ecological study.
Hungerford D; Macpherson P; Farmer S; Ghebrehewet S; Seddon D; Vivancos R; Keenan A
Epidemiol Infect; 2016 Apr; 144(6):1201-11. PubMed ID: 26542197
[TBL] [Abstract][Full Text] [Related]
2. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the measles, mumps and rubella vaccination catch-up campaign in England in 2013.
Simone B; Balasegaram S; Gobin M; Anderson C; Charlett A; Coole L; Maguire H; Nichols T; Rawlings C; Ramsay M; Oliver I
Vaccine; 2014 Aug; 32(36):4681-8. PubMed ID: 24996125
[TBL] [Abstract][Full Text] [Related]
4. The two-dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate.
Pareek M; Pattison HM
Br J Gen Pract; 2000 Dec; 50(461):969-71. PubMed ID: 11224968
[TBL] [Abstract][Full Text] [Related]
5. A novel measles outbreak control strategy in the Netherlands in 2013-2014 using a national electronic immunization register: A study of early MMR uptake and its determinants.
Nic Lochlainn LM; Woudenberg T; van Lier A; Zonnenberg I; Philippi M; de Melker HE; Hahné SJM
Vaccine; 2017 Oct; 35(43):5828-5834. PubMed ID: 28923422
[TBL] [Abstract][Full Text] [Related]
6. Measles outbreaks in the UK, is it when and where, rather than if? A database cohort study of childhood population susceptibility in Liverpool, UK.
Keenan A; Ghebrehewet S; Vivancos R; Seddon D; MacPherson P; Hungerford D
BMJ Open; 2017 Mar; 7(3):e014106. PubMed ID: 28363926
[TBL] [Abstract][Full Text] [Related]
7. Impact of adverse publicity on MMR vaccine uptake: a population based analysis of vaccine uptake records for one million children, born 1987-2004.
Friederichs V; Cameron JC; Robertson C
Arch Dis Child; 2006 Jun; 91(6):465-8. PubMed ID: 16638784
[TBL] [Abstract][Full Text] [Related]
8. Understanding variation in measles-mumps-rubella immunization coverage--a population-based study.
Wright JA; Polack C
Eur J Public Health; 2006 Apr; 16(2):137-42. PubMed ID: 16207728
[TBL] [Abstract][Full Text] [Related]
9. Impact of pregnancy vaccine uptake and socio-demographic determinants on subsequent childhood Measles, Mumps and Rubella vaccine uptake: A UK birth cohort study.
Skirrow H; Foley K; Bedford H; Lewis C; Whittaker E; Costelloe C; Saxena S
Vaccine; 2024 Jan; 42(2):322-331. PubMed ID: 38072757
[TBL] [Abstract][Full Text] [Related]
10. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
Zäch K; Nicoara C; Germann D; Matter L
Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
[TBL] [Abstract][Full Text] [Related]
11. The effect of geographical variation in income measures on measles-mumps-rubella uptake and coverage in England; a protocol for an ecological study.
Ghazal S; Soyiri IN
PLoS One; 2023; 18(6):e0280008. PubMed ID: 37379282
[TBL] [Abstract][Full Text] [Related]
12. Measles vaccination coverage among five-year-old children: implications for disease elimination in Australia.
Lawrence GL; MacIntyre CR; Hull BP; McIntyre PB
Aust N Z J Public Health; 2003; 27(4):413-8. PubMed ID: 14705304
[TBL] [Abstract][Full Text] [Related]
13. Measles, mumps and rubella: control by vaccination.
van Druten JA; de Boo T; Plantinga AD
Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
[TBL] [Abstract][Full Text] [Related]
14. MMR vaccine uptake rates: a data validation study.
Ghebrehewet S; Falconer M; McDonald P; Schlecht B
Commun Dis Public Health; 2003 Jun; 6(2):144-6. PubMed ID: 12889295
[TBL] [Abstract][Full Text] [Related]
15. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations.
Fombonne E; Zakarian R; Bennett A; Meng L; McLean-Heywood D
Pediatrics; 2006 Jul; 118(1):e139-50. PubMed ID: 16818529
[TBL] [Abstract][Full Text] [Related]
16. Improving MMR vaccination rates: herd immunity is a realistic goal.
Cockman P; Dawson L; Mathur R; Hull S
BMJ; 2011 Oct; 343():d5703. PubMed ID: 21971162
[TBL] [Abstract][Full Text] [Related]
17. Lack of association between measles-mumps-rubella vaccination and autism in children: a case-control study.
Mrozek-Budzyn D; Kiełtyka A; Majewska R
Pediatr Infect Dis J; 2010 May; 29(5):397-400. PubMed ID: 19952979
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of measles, mumps & rubella vaccine at 9 & 15 months of age.
Yadav S; Thukral R; Chakarvarti A
Indian J Med Res; 2003 Nov; 118():183-6. PubMed ID: 14723482
[TBL] [Abstract][Full Text] [Related]
19. MMR vaccination status of children exempted from school-entry immunization mandates.
Buttenheim AM; Sethuraman K; Omer SB; Hanlon AL; Levy MZ; Salmon D
Vaccine; 2015 Nov; 33(46):6250-6. PubMed ID: 26431991
[TBL] [Abstract][Full Text] [Related]
20. Childhood MMR vaccination and the incidence rate of measles infection: a ten year longitudinal cohort study of American children born in the 1990s.
Geier DA; Kern JK; Geier MR
BMC Pediatr; 2019 Sep; 19(1):325. PubMed ID: 31506095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
